MilroyJSamuelMD

Preventive Medicine • Columbus, OH

Addiction Medicine

Complete Healthcare Addiction & Gynecology

Join to view full profile

Dr. Samuel is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Samuel's full profile

Already have an account?

Office
5910 Cleveland Ave
Columbus, OH 43231
Phone+1 614-882-4343

Fax+1 614-882-4664

Education & Training

Ohio State University/Mt Carmel HospitalResidency, Obstetrics and Gynecology, 1997 - 2001
Meharry Medical CollegeClass of 1997

Certifications & Licensure

OH State Medical License 1998 - 2026
FL State Medical License 2001 - 2025
American Board of Obstetrics and Gynecology Obstetrics & Gynecology
American Board of Preventive Medicine Addiction Medicine

Awards, Honors, & Recognition

Regional Top Doctor Castle Connolly, 2014
Most Compassionate Doctor American Registry
Fellow (FACOG) American Congress of Obstetricians and Gynecologists

Clinical Trials

HOME Study: Hysteroscopic Office Myomectomy Evaluation Start of enrollment: 2010 Jun 01
Completed
Not Applicable
Clinical Evaluation of the SEQureDx T21 Test In High Risk Pregnancies Start of enrollment: 2012 Mar 01
Completed
A Multicenter Trial of the Efficacy and Safety of Diclegis® for Nausea and Vomiting of Pregnancy in Pregnant Adolescents Start of enrollment: 2014 Feb 01
Terminated
Phase 4
Safety and Efficacy of Oral Encochleated Amphotericin B (CAMB/MAT2203) in the Treatment of Vulvovaginal Candidiasis (VVC) Start of enrollment: 2016 Nov 01
Completed
Phase 2
Join now to see all

Publications & Presentations

PubMed

10 citations
A Phase 3, Multicenter, Prospective, Open-Label Study to Evaluate the Safety of a Single Dose of Secnidazole 2 g for the Treatment of Women and Postmenarchal Adolescen...
Steven E. Chavoustie, Janet K Gersten, Milroy J Samuel, Jane R. Schwebke
Journal of Women's Health. 2018-01-11
Abnormal human chorionic gonadotropin levels and normal pregnancy outcomes in the ovarian hyperstimulation syndrome.
Milroy J Samuel, Clemens M Grosskinsky
The Journal of Reproductive Medicine. 2004-01-01

Authored Content

A Phase 3, Multicenter, Prospective, Open-Label Study to Evaluate the Safety of a Single Dose of Secnidazole 2 G for the Treatment of Women and Postmenarchal Adolescent Girls with Bacterial VaginosisJanuary 2018

Professional Memberships

American College of Obstetricians and Gynecologists
Fellow